CHRISTINA STARKEY: Open Payments
NPI 1154066397 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 21 payments from 11 companies in 2025. Trend: 2023 $589 · 2024 $319 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Tris Pharma Inc | 2 | $37 |
| Alkermes, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Corium, LLC | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, Azstarys, Onyda XR, Relexxii, Dyanavel XR.
Industry payments across CO — which companies pay providers there.
